miR⁃449c通过抑制c⁃Myc的表达抑制肺腺癌细胞周期进程
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R734.2

基金项目:

江苏省卫计委科研项目(Z2018047)


miR⁃449c inhibits the cell cycle progression of lung adenocarcinoma cells by inhibiting the expression of c⁃Myc
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨miR-449c对肺腺癌发生发展的影响及可能机制。方法:利用生物信息学分析鉴定高复发风险肺腺癌患者(无病生存期≤6个月)与低复发风险患者(无病生存期>60个月)之间差异表达的microRNA(miRNA)。靶基因预测及通路分析研究可能的机制。RT-PCR检测miR-449c在肺腺癌组织和细胞系中的表达,利用细胞转染实验在肺腺癌细胞系中过表达 miR-449c和c-Myc,CCK-8法测定细胞增殖活性,流式细胞术检测细胞周期及凋亡,蛋白质印迹分析检测相关蛋白表达水平。结果:生物信息学分析结果显示,相比低复发风险患者,肺腺癌高复发风险患者的miR-449c表达显著降低。miR-449c表达水平与肺腺癌患者临床分期和淋巴结转移相关,miR-449c低表达患者的预后显著差于高表达患者。通路和功能分析表明,miR- 449c可能与细胞周期进程有关。与癌旁组织相比,miR-449c在肺腺癌组织中显著低表达;过表达miR-449c抑制了肺腺癌细胞增殖,导致细胞周期阻滞于G1期,下调了c-Myc及其下游细胞周期蛋白的表达。c-Myc过表达可部分逆转miR-449c对细胞周期蛋白的抑制,miR-449c过表达也可部分逆转c-Myc对细胞周期蛋白的上调。结论:miR-449c低表达的肺腺癌患者预后较差,过表达miR-449c可以通过下调c-Myc调控细胞周期,抑制肺腺癌细胞增殖,提示miR-449c可能作为肺腺癌潜在的治疗靶标之一。

    Abstract:

    Objective:The purpose of the current study was to explore the effect and possible mechanism of miR-449c on the occurrence and development of lung adenocarcinoma. Methods:Bioinformatics analysis was used to identify the differentially expressed microRNAs between samples with lung adenocarcinoma patients at a high risk of recurrence(disease-free survival ≤6 months)and samples with lung adenocarcinoma patients at a low risk of recurrence(disease -free survival >60 months). Target gene prediction and pathway analysis were used to analysis possible mechanisms. RT-PCR was used to detect the expression of miR-449c in lung adenocarcinoma tissues and cell lines. miR-449c and c-Myc were overexpressed in lung adenocarcinoma cell lines by cell transfection experiments. Cell growth activity was determined by CCK-8. Cell cycle and apoptosis were detected by flow cytometry. Western blot analysis was used for relevant protein expression. Results:The results of bioinformatics analysis showed that the expression of miR-449c was significantly decreased in the group of lung adenocarcinoma patients at a high risk of recurrence, compared with that at a low risk of recurrence. The expression of miR-449c was significantly correlated with the clinical stage and lymph node metastasis of patients with lung adenocarcinoma. The prognosis of patients with low miR-449c expression was significantly worse than that of patients with high miR-449c expression. Pathway and functional analysis indicated that miR-449c may be involved in cell cycle progression. Compared with normal tissues,miR-449c was significantly lower expressed in lung adenocarcinoma tissues.Overexpression of miR-449c inhibited lung adenocarcinoma cell proliferation,resulted in cell cycle arrest in G1 phase,and downregulated the expression of c-Myc and its downstream cyclins. Overexpression of c-Myc could partially counteract the inhibition of cyclin by miR -449c. Overexpression of miR-449c could also partially counteract the up-regulation of cyclin expression by c -Myc. Conclusion:Lung adenocarcinoma patients with low expression of miR-449c have a poor prognosis. Overexpression of miR-449c can regulate the lung adenocarcinoma cell cycle by downregulating c -Myc to inhibit the proliferation of lung adenocarcinoma cells. The results suggest that miR-449c may be one of the potential therapeutic targets for lung adenocarcinoma.

    参考文献
    相似文献
    引证文献
引用本文

娄芮,朱佳浩,茆勇,曹海霞. miR⁃449c通过抑制c⁃Myc的表达抑制肺腺癌细胞周期进程[J].南京医科大学学报(自然科学版),2023,(11):1494-1502

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-03-01
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-17
  • 出版日期:
通知关闭
郑重声明